Literature DB >> 19821492

Anthropometric measures and epithelial ovarian cancer risk in the European Prospective Investigation into Cancer and Nutrition.

Petra H Lahmann1, Anne E Cust, Christine M Friedenreich, Mandy Schulz, Annekatrin Lukanova, Rudolf Kaaks, Eva Lundin, Anne Tjønneland, Jytte Halkjaer, Marianne Tang Severinsen, Kim Overvad, Agnès Fournier, Nathalie Chabbert-Buffet, Françoise Clavel-Chapelon, Laure Dossus, Tobias Pischon, Heiner Boeing, Antonia Trichopoulou, Pagona Lagiou, Androniki Naska, Domenico Palli, Sara Grioni, Amalia Mattiello, Rosario Tumino, Carlotta Sacerdote, María-Luisa Redondo, Paula Jakszyn, María-José Sánchez, María-José Tormo, Eva Ardanaz, Larraitz Arriola, Jonas Manjer, Karin Jirström, H Bas Bueno-de-Mesquita, Anne M May, Petra H M Peeters, N Charlotte Onland-Moret, Sheila Bingham, Kay-Tee Khaw, Naomi E Allen, Elizabeth Spencer, Sabina Rinaldi, Nadia Slimani, Véronique Chajes, Dominique Michaud, Teresa Norat, Elio Riboli.   

Abstract

We examined the associations of measured anthropometric factors, including general and central adiposity and height, with ovarian cancer risk. We also investigated these associations by menopausal status and for specific histological subtypes. Among 226,798 women in the European Prospective Investigation into Cancer and Nutrition (EPIC) cohort, there were 611 incident cases of primary, malignant, epithelial ovarian cancer diagnosed during a mean 8.9 years of follow-up. Cox proportional hazards models were used to estimate hazard ratios (HRs) and 95% confidence intervals (CIs), adjusted for potential confounders. Compared to women with body mass index (BMI) < 25 kg/m2, obesity (BMI > or = 30 kg/m2) was associated with excess ovarian cancer risk for all women combined (HR = 1.33, 95% CI = 1.05-1.68; p(trend) = 0.02) and postmenopausal women (HR = 1.59, 95% CI = 1.20-2.10; p(trend) = 0.001), but the association was weaker for premenopausal women (HR = 1.16, 95% CI = 0.65-2.06; p(trend) = 0.65). Neither height or weight gain, nor BMI-adjusted measures of fat distribution assessed by waist circumference, waist-hip ratio (WHR) or hip circumference were associated with overall risk. WHR was related to increased risk of mucinous tumors (BMI-adjusted HR per 0.05 unit increment = 1.17, 95% CI = 1.00-1.38). For all women combined, no other significant associations with risk were observed for specific histological subtypes. This large, prospective study provides evidence that obesity is an important modifiable risk factor for epithelial ovarian cancer, particularly among postmenopausal women.

Entities:  

Mesh:

Year:  2010        PMID: 19821492     DOI: 10.1002/ijc.24952

Source DB:  PubMed          Journal:  Int J Cancer        ISSN: 0020-7136            Impact factor:   7.396


  31 in total

1.  Body size and the risk of ovarian cancer by hormone therapy use in the California Teachers Study cohort.

Authors:  Alison J Canchola; Ellen T Chang; Leslie Bernstein; Joan A Largent; Peggy Reynolds; Dennis Deapen; Katherine D Henderson; Giske Ursin; Pamela L Horn-Ross
Journal:  Cancer Causes Control       Date:  2010-10-06       Impact factor: 2.506

2.  Obesity as a risk factor in cancer: A national consensus of the Spanish Society for the Study of Obesity and the Spanish Society of Medical Oncology.

Authors:  A Goday; I Barneto; J M García-Almeida; A Blasco; A Lecube; C Grávalos; P Martínez de Icaya; R de las Peñas; S Monereo; L Vázquez; J E Palacio; P Pérez-Segura
Journal:  Clin Transl Oncol       Date:  2015-06-03       Impact factor: 3.405

Review 3.  Revisiting the role of antiandrogen strategies in ovarian cancer.

Authors:  Dionysis Papadatos-Pastos; Konstantin J Dedes; Johann S de Bono; Stanley B Kaye
Journal:  Oncologist       Date:  2011-09-23

4.  Socioeconomic Status in Relation to the Risk of Ovarian Cancer in African-American Women: A Population-Based Case-Control Study.

Authors:  Anthony J Alberg; Patricia G Moorman; Sydnee Crankshaw; Frances Wang; Elisa V Bandera; Jill S Barnholtz-Sloan; Melissa Bondy; Kathleen B Cartmell; Michelle L Cote; Marvella E Ford; Ellen Funkhouser; Linda E Kelemen; Edward S Peters; Ann G Schwartz; Katherine Regan Sterba; Paul Terry; Kristin Wallace; Joellen M Schildkraut
Journal:  Am J Epidemiol       Date:  2016-08-03       Impact factor: 4.897

5.  Obesity and risks for malignant melanoma and non-melanoma skin cancer: results from a large Danish prospective cohort study.

Authors:  Camilla Præstegaard; Susanne K Kjær; Jane Christensen; Anne Tjønneland; Jytte Halkjær; Allan Jensen
Journal:  J Invest Dermatol       Date:  2014-10-07       Impact factor: 8.551

6.  Diet quality and survival after ovarian cancer: results from the Women's Health Initiative.

Authors:  Cynthia A Thomson; Tracy E Crane; Betsy C Wertheim; Marian L Neuhouser; Wenjun Li; Linda G Snetselaar; Karen M Basen-Engquist; Yang Zhou; Melinda L Irwin
Journal:  J Natl Cancer Inst       Date:  2014-10-21       Impact factor: 13.506

7.  Anthropometric characteristics and ovarian cancer risk and survival.

Authors:  Albina N Minlikeeva; Kirsten B Moysich; Paul C Mayor; John L Etter; Rikki A Cannioto; Roberta B Ness; Kristen Starbuck; Robert P Edwards; Brahm H Segal; Sashikant Lele; Kunle Odunsi; Brenda Diergaarde; Francesmary Modugno
Journal:  Cancer Causes Control       Date:  2018-01-11       Impact factor: 2.506

8.  Ovarian cancer risk factors by histologic subtypes in the NIH-AARP Diet and Health Study.

Authors:  Hannah P Yang; Britton Trabert; Megan A Murphy; Mark E Sherman; Joshua N Sampson; Louise A Brinton; Patricia Hartge; Albert Hollenbeck; Yikyung Park; Nicolas Wentzensen
Journal:  Int J Cancer       Date:  2011-11-10       Impact factor: 7.396

9.  Obesity Contributes to Ovarian Cancer Metastatic Success through Increased Lipogenesis, Enhanced Vascularity, and Decreased Infiltration of M1 Macrophages.

Authors:  Yueying Liu; Matthew N Metzinger; Kyle A Lewellen; Stephanie N Cripps; Kyle D Carey; Elizabeth I Harper; Zonggao Shi; Laura Tarwater; Annie Grisoli; Eric Lee; Ania Slusarz; Jing Yang; Elizabeth A Loughran; Kaitlyn Conley; Jeff J Johnson; Yuliya Klymenko; Lana Bruney; Zhong Liang; Norman J Dovichi; Bentley Cheatham; W Matthew Leevy; M Sharon Stack
Journal:  Cancer Res       Date:  2015-11-16       Impact factor: 12.701

10.  Body mass index and cancer incidence: the FINRISK study.

Authors:  Xin Song; Eero Pukkala; Tadeusz Dyba; Jaakko Tuomilehto; Vladislav Moltchanov; Satu Männistö; Pekka Jousilahti; Qing Qiao
Journal:  Eur J Epidemiol       Date:  2014-07-06       Impact factor: 8.082

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.